- Home
- JEQ vs KRRO Comparison
JEQ vs KRRO Comparison
Compare JEQ & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEQ
- KRRO
- Stock Information
- Founded
- JEQ 1990
- KRRO 2014
- Country
- JEQ United States
- KRRO United States
- Employees
- JEQ N/A
- KRRO N/A
- Industry
- JEQ Air Freight/Delivery Services
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- JEQ Consumer Discretionary
- KRRO Health Care
- Exchange
- JEQ Nasdaq
- KRRO Nasdaq
- Market Cap
- JEQ 99.8M
- KRRO 101.4M
- IPO Year
- JEQ N/A
- KRRO 2019
- Fundamental
- Price
- JEQ $7.51
- KRRO $12.77
- Analyst Decision
- JEQ
- KRRO Strong Buy
- Analyst Count
- JEQ 0
- KRRO 7
- Target Price
- JEQ N/A
- KRRO $85.67
- AVG Volume (30 Days)
- JEQ 32.0K
- KRRO 178.3K
- Earning Date
- JEQ 01-01-0001
- KRRO 08-12-2025
- Dividend Yield
- JEQ 7.05%
- KRRO N/A
- EPS Growth
- JEQ N/A
- KRRO N/A
- EPS
- JEQ N/A
- KRRO N/A
- Revenue
- JEQ N/A
- KRRO $4,821,000.00
- Revenue This Year
- JEQ N/A
- KRRO $65.08
- Revenue Next Year
- JEQ N/A
- KRRO N/A
- P/E Ratio
- JEQ N/A
- KRRO N/A
- Revenue Growth
- JEQ N/A
- KRRO N/A
- 52 Week Low
- JEQ $4.99
- KRRO $10.29
- 52 Week High
- JEQ $6.39
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- JEQ 68.54
- KRRO 47.09
- Support Level
- JEQ $6.94
- KRRO $11.52
- Resistance Level
- JEQ $7.62
- KRRO $12.86
- Average True Range (ATR)
- JEQ 0.14
- KRRO 0.97
- MACD
- JEQ 0.02
- KRRO 0.05
- Stochastic Oscillator
- JEQ 64.52
- KRRO 25.19
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.